Compare APRE & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APRE | LUCY |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 6.0M |
| IPO Year | 2019 | N/A |
| Metric | APRE | LUCY |
|---|---|---|
| Price | $0.72 | $1.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 231.3K | 74.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $80.76 |
| Revenue Next Year | N/A | $210.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.95 |
| 52 Week High | $2.65 | $5.56 |
| Indicator | APRE | LUCY |
|---|---|---|
| Relative Strength Index (RSI) | 41.59 | 45.70 |
| Support Level | $0.55 | $0.98 |
| Resistance Level | $0.98 | $1.22 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 2.44 | 31.62 |
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.